These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 23322460)
1. Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis. Caminero A; Comabella M; Montalban X Clin Exp Immunol; 2011 Dec; 166(3):338-45. PubMed ID: 22059991 [TBL] [Abstract][Full Text] [Related]
2. The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome. Lee SJ; Baek JY; Lee JY; Kang JM; Ahn JG Yonsei Med J; 2024 Apr; 65(4):241-245. PubMed ID: 38515362 [TBL] [Abstract][Full Text] [Related]
3. Somatic mosaicism in adult-onset TNF receptor-associated periodic syndrome (TRAPS). Kontzias A; Zarabi SK; Calabrese C; Wang Y; Judis L; Yao Q; Cheng YW Mol Genet Genomic Med; 2019 Aug; 7(8):e791. PubMed ID: 31397119 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome. Terré A; Vautier M; Kahn JE; Georgin-Lavialle S; Boursier G Eur J Intern Med; 2024 May; 123():156-158. PubMed ID: 38307733 [No Abstract] [Full Text] [Related]
5. A novel TNFRSF1A mutation associated with TNF-receptor-associated periodic syndrome and its metabolic signature. Steiner JD; Annibal A; Laboy R; Braumann M; Göbel H; Laasch V; Müller RU; Späth MR; Antebi A; Kubacki T Rheumatology (Oxford); 2023 Oct; 62(10):3459-3468. PubMed ID: 36752501 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor receptor-associated cycle syndrome: a case report and literature review. Li Z; Jing X; Zhang S; Liu T; Guo Q Front Pediatr; 2023; 11():1296487. PubMed ID: 38155741 [TBL] [Abstract][Full Text] [Related]
7. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Lachmann HJ; Papa R; Gerhold K; Obici L; Touitou I; Cantarini L; Frenkel J; Anton J; Kone-Paut I; Cattalini M; Bader-Meunier B; Insalaco A; Hentgen V; Merino R; Modesto C; Toplak N; Berendes R; Ozen S; Cimaz R; Jansson A; Brogan PA; Hawkins PN; Ruperto N; Martini A; Woo P; Gattorno M; Ann Rheum Dis; 2014 Dec; 73(12):2160-7. PubMed ID: 23965844 [TBL] [Abstract][Full Text] [Related]
8. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. Cantarini L; Rigante D; Merlini G; Vitale A; Caso F; Lucherini OM; Sfriso P; Frediani B; Punzi L; Galeazzi M; Cimaz R; Obici L Semin Arthritis Rheum; 2014 Jun; 43(6):818-23. PubMed ID: 24393624 [TBL] [Abstract][Full Text] [Related]
9. A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases. Galozzi P; Negm O; Bindoli S; Tighe P; Sfriso P; Punzi L Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163749 [TBL] [Abstract][Full Text] [Related]
10. Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants. Mulazzani E; Wagner D; Havla J; Schlüter M; Meinl I; Gerdes LA; Kümpfel T J Neuroinflammation; 2020 Jun; 17(1):196. PubMed ID: 32563262 [TBL] [Abstract][Full Text] [Related]